Clinical features, risk factors, diagnosis, and treatment of trimethoprim-sulfamethoxazole-induced hypoglycemia
ObjectiveHypoglycemia is a sporadic and serious adverse reaction of trimethoprim-sulfamethoxazole (TMP-SMX) due to its sulfonylurea-like effect. This study explored the clinical characteristics, risk factors, treatment, and prognosis of TMP-SMX-induced hypoglycemia.MethodsCase reports and series of...
Main Authors: | Chunjiang Wang, Weijin Fang, Zuojun Li, Linli Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1059522/full |
Similar Items
-
Analysis on Prophylaxis of Pneumocystis Carini Pneumonia by Trimethoprim-Sulfamethoxazole in Patients with Autoimmune Diseases
by: QUE Yongtu, et al.
Published: (2023-01-01) -
Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection
by: Hui Qi, et al.
Published: (2023-06-01) -
Efficacy of Trimethoprim–Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis
by: Hideo Kato, et al.
Published: (2022-05-01) -
Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study
by: Ruo-Yang Chen, et al.
Published: (2022-12-01) -
An unexpected cause of hyponatremia in a cancer patient: Trimethoprim-sulfamethoxazole
by: Dilsa Mizrak, et al.
Published: (2016-04-01)